日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial

帕博利珠单抗联合化疗治疗晚期或复发性子宫内膜癌:NRG GY018 3期随机试验的总生存期和探索性分析

Eskander, Ramez N; Sill, Michael W; Beffa, Lindsey; Moore, Richard G; Hope, Joanie M; Musa, Fernanda B; Mannel, Robert S; Shahin, Mark S; Cantuaria, Guilherme H; Girda, Eugenia; Lokich, Elizabeth; Kavecansky, Juraj; Leath, Charles A 3rd; Gien, Lilian T; Hinchcliff, Emily M; Lele, Shashikant B; Landrum, Lisa M; Backes, Floor; O'Cearbhaill, Roisin E; Baghdadi, Tareq Al; Hill, Emily K; Thaker, Premal H; John, Veena S; Welch, Stephen; Fader, Amanda N; Powell, Matthew A; Aghajanian, Carol

Cediranib and Olaparib Combination Compared With Cediranib or Olaparib Alone, or Chemotherapy in Platinum-Resistant or Primary Platinum-Refractory Ovarian Cancer: NRG-GY005

在铂类耐药或原发性铂类难治性卵巢癌中,西地尼布联合奥拉帕尼与单用西地尼布或奥拉帕尼,或化疗的疗效比较:NRG-GY005

Lee, Jung-Min; Brady, Mark F; Miller, Austin; Moore, Richard G; MacKay, Helen; McNally, Leah; Lea, Jayanthi; Street, Daron; Lheureux, Stephanie; McDonald, Megan E; Duska, Linda R; Cantuaria, Guilherme; Kavecansky, Juraj; Leath, Charles A 3rd; Powell, Matthew; Cadungog, Mark G; Rose, Peter G; Kim, Yong-Man; Huang, Helen Q; Provencher, Michèle; Wenzel, Lari B; Bookman, Michael A; Kohn, Elise C; Secord, Angeles Alvarez

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

帕博利珠单抗联合化疗治疗晚期子宫内膜癌

Eskander, Ramez N; Sill, Michael W; Beffa, Lindsey; Moore, Richard G; Hope, Joanie M; Musa, Fernanda B; Mannel, Robert; Shahin, Mark S; Cantuaria, Guilherme H; Girda, Eugenia; Mathews, Cara; Kavecansky, Juraj; Leath, Charles A 3rd; Gien, Lilian T; Hinchcliff, Emily M; Lele, Shashikant B; Landrum, Lisa M; Backes, Floor; O'Cearbhaill, Roisin E; Al Baghdadi, Tareq; Hill, Emily K; Thaker, Premal H; John, Veena S; Welch, Stephen; Fader, Amanda N; Powell, Matthew A; Aghajanian, Carol

Role of neighborhood context in ovarian cancer survival disparities: current research and future directions

社区环境在卵巢癌生存差异中的作用:当前研究与未来方向

Gomez, Scarlett L; Chirikova, Ekaterina; McGuire, Valerie; Collin, Lindsay J; Dempsey, Lauren; Inamdar, Pushkar P; Lawson-Michod, Katherine; Peters, Edward S; Kushi, Lawrence H; Kavecansky, Juraj; Shariff-Marco, Salma; Peres, Lauren C; Terry, Paul; Bandera, Elisa V; Schildkraut, Joellen M; Doherty, Jennifer A; Lawson, Andrew

Sociodemographic disparities in targeted therapy in ovarian cancer in a national sample

全国样本中卵巢癌靶向治疗的社会人口学差异

Amin, Saber A; Collin, Lindsay J; Kavecansky, Juraj; Setoguchi, Soko; Satagopan, Jaya M; Bandera, Elisa V

Association of anticoagulation use with SARS-CoV2 detection

抗凝药物使用与SARS-CoV-2检测的关联

Kavecansky, Juraj; Dusendang, Jennifer R; Tavakoli, Jahan; Schmittdiel, Julie; Ho, Gwendolyn; Loyles, Jodi; Pai, Ashok

Chromosome breakage is regulated by the interaction of the BLM helicase and topoisomerase IIalpha

染色体断裂受 BLM 解旋酶和拓扑异构酶 IIalpha 相互作用调控

Beatriz Russell, Saumitri Bhattacharyya, Jeremy Keirsey, April Sandy, Patrick Grierson, Erin Perchiniak, Juraj Kavecansky, Samir Acharya, Joanna Groden

Telomerase-associated protein 1, HSP90, and topoisomerase IIalpha associate directly with the BLM helicase in immortalized cells using ALT and modulate its helicase activity using telomeric DNA substrates

端粒酶相关蛋白 1、HSP90 和拓扑异构酶 IIalpha 利用 ALT 直接与永生化细胞中的 BLM 解旋酶结合,并使用端粒 DNA 底物调节其解旋酶活性

Saumitri Bhattacharyya, Jeremy Keirsey, Beatriz Russell, Juraj Kavecansky, Kate Lillard-Wetherell, Kambiz Tahmaseb, John J Turchi, Joanna Groden